Editorial: Advances in combined modality treatments for prostate cancer

Feifei Sun · 2026

Read Editorial: Advances in combined modality treatments for prostate cancer by Feifei Sun (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13627427.txt.

Description

Feifei Sun introduces a set of studies on combining treatments for prostate cancer, in this 2026 editorial. Care for this cancer has moved away from a single treatment at a time. Doctors now pair surgery or radiation with hormone-blocking drugs, newer hormone agents, chemotherapy, and experimental targeted drugs. Combinations control the disease better, but they also make choices harder for each patient.

The seven articles in the set follow the disease from early to advanced stages. Some refine local treatment and therapy given before surgery. Others sort out stronger drug mixes for cancer that has spread but still answers to hormone treatment. A final group probes why late-stage cancer stops responding and tests new candidates against it. The editor frames the shared question: not whether to combine, but which mix suits which man at which stage.

Catalog record

CREATORFeifei Sun
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE7 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13627427

Browse the full library · About the Tower of Babel